Perhaps most notably, Lonza has telegraphed its intention to hive off its capsules and health ingredients (CHI) business “at the appropriate time.” In July, Lonza noted that CHI sales were ...

Swiss contract drugmaker Lonza (LONN.S), opens new tab plans to simplify its structure and exit its capsules and health ingredients (CHI) business after a decline in demand for pharmaceutical ...